"The companies mutually terminated the deal, which was originally announced in late February 2022, due to uncertainty around TD's ability to obtain regulatory approval and when.
On this news, shares of First Horizon fell by more than 36%. TD's shares, listed on the New York Stock Exchange, remained unchanged.
Brian Jordan, CEO of First Horizon, said, "While today's announcement is disappointing and unexpected, First Horizon will continue its growth trajectory, operating from a position of strength and stability."
"Our strong capital position, disciplined credit quality, expense control measures, and well-diversified and stable funding base have enabled our business to navigate the challenging dynamics of the banking industry and remain focused on executing our customer-focused growth plan," he continued."
"On April 25, 2023, the Momentum Indicator of FHN moved below the 0 level, indicating a potential sell signal. In such cases, traders may want to consider selling the stock, shorting the stock, or exploring put options on FHN as a result. Based on historical data, in 48 out of 84 instances where the Momentum Indicator fell below 0, the stock fell further within the subsequent month, resulting in a 57% chance of a continued downward trend.
Moreover, the Moving Average Convergence Divergence Histogram (MACD) for FHN turned negative on May 02, 2023, which could be an indication of a further decline in the stock's price in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor analyzed 43 similar instances when the MACD indicator turned negative, and found that in 24 of those cases, the stock turned lower in the days that followed, resulting in a 56% chance of success."
The 10-day moving average for FHN crossed bearishly below the 50-day moving average on October 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on November 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FHN as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
FHN moved below its 50-day moving average on October 15, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FHN's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for FHN just turned positive on November 19, 2025. Looking at past instances where FHN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FHN advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .
FHN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 53, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.220) is normal, around the industry mean (1.094). P/E Ratio (12.831) is within average values for comparable stocks, (17.823). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.156). Dividend Yield (0.028) settles around the average of (0.037) among similar stocks. P/S Ratio (3.505) is also within normal values, averaging (5.120).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FHN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks